martes, 29 de septiembre de 2015

HHS advances development of novel drug to treat influenza

Dept. of Health & Human Services

A monoclonal antibody therapeutic drug, a novel approach to treating patients with influenza, will advance in development with funding from the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR).

Read more about today's announcement
Tweet This

No hay comentarios:

Publicar un comentario